BioSpace News Archive

Advanced Infusion Care (AIC), a division of AIS Healthcare, today announced its participation in the Immunoglobulin National Society (IgNS) 12th National Conference, which takes place on October 5th – 8th in Denver, Colorado.

RevBio, Inc., announced that it has been awarded a grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), through its Commercialization Readiness Program of up to $3.4 million over the next three years (1SB1AG085803-01).

Atara Biotherapeutics, Inc. reported the grant of 56,750 restricted stock units of Atara’s common stock to four newly hired employees.

PN Medical, a cardiopulmonary device manufacturer developing combined respiratory muscle training (cRMT) devices, today announced that it has initiated a study to evaluate its flagship device

Addex Therapeutics announced that it plans to change the ratio of its American Depositary Shares to its ordinary shares from the current ADS Ratio of one ADS to six ordinary shares to a new ADS Ratio of one ADS to one hundred and twenty ordinary shares.

Syndax Pharmaceuticals announced that on October 1, 2023 the Company granted inducement awards to purchase up to 121,150 shares of common stock to eight new employees under the Company’s 2023 Inducement Plan.

Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced the grant of inducement awards to four new employees.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Novartis, a global leader in immuno-dermatology and rheumatology, announced today that the US Food and Drug Administration (FDA) has approved an intravenous (IV) formulation of Cosentyx® (secukinumab) for the treatment of adults with psoriatic arthritis (PsA), ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA).

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its third quarter 2023 financial results on Wednesday, November 8, 2023, at 7:00 a.m. ET.